Cargando…
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
Abnormal glucose metabolism and enhanced oxidative stress accelerate cardiovascular disease, a chronic inflammatory condition causing high morbidity and mortality. Here, we report that in monocytes and macrophages of patients with atherosclerotic coronary artery disease (CAD), overutilization of glu...
Autores principales: | Shirai, Tsuyoshi, Nazarewicz, Rafal R., Wallis, Barbara B., Yanes, Rolando E., Watanabe, Ryu, Hilhorst, Marc, Tian, Lu, Harrison, David G., Giacomini, John C., Assimes, Themistocles L., Goronzy, Jörg J., Weyand, Cornelia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813677/ https://www.ncbi.nlm.nih.gov/pubmed/26926996 http://dx.doi.org/10.1084/jem.20150900 |
Ejemplares similares
-
T Cell–Macrophage Interactions and Granuloma Formation in Vasculitis
por: Hilhorst, Marc, et al.
Publicado: (2014) -
PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways
por: Xu, Danyi, et al.
Publicado: (2019) -
HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma
por: Huang, Jiajun, et al.
Publicado: (2021) -
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
por: Gao, Lixia, et al.
Publicado: (2023) -
T-cell co-stimulatory pathways in autoimmunity
por: Goronzy, Jörg J, et al.
Publicado: (2008)